Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1
Recruiting1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04274816Phase 1Completed
Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma
Cutaneous Melanoma
PrincipalinvestigatorStart date: 2012-07-10

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Amsterdam UMC, location VUmc

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04126876Phase 2PrincipalInvestigator

A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma

Malignant Melanoma
Recruiting
NCT04274816Phase 1PrincipalInvestigator

Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma

Cutaneous Melanoma
Completed

All 2 trials loaded